Towards new antibacterial drugs to treat infections caused by multidrug-resistant bacteria: identification and characterization of novel natural product antibiotics at University of Leeds on FindAPhD.com

Dr A O'Neill Applications accepted all year round Self-Funded PhD Students Only

Email institution

Institution website

Add to
shortlist

Remove from
shortlist

Institution
profile

COVID-19 Information

Email institution

Leeds United Kingdom Medical / Clinical Science Microbiology Molecular Biology

Faculty of Biological Sciences, University of Leeds

About the Project

The World Health Organization (WHO) has declared antimicrobial drug resistance one of the greatest problems currently facing human health, and the situation is especially grave in the case of infections caused by bacterial pathogens. Compounding the issue, in the last 40 years only two structurally-novel antibacterial classes have been successfully developed for treating life-threatening bacterial infections.

The majority of our existing antibacterial armamentarium are microbial products; despite this, most antibacterial drug discovery programmes have abandoned the search for novel natural product antibiotics, favoring instead rational synthetic chemistry approaches which have yet to bear fruit.

The proposed studentship intends to utilize several innovative approaches to find and characterize novel antibiotic classes produced by micro-organisms, with a view to ultimately developing drugs active against multi-drug resistant bacterial pathogens such as Staphylococcus aureus and Pseudomonas aeruginosa.

Funding Notes

Please visit View Website

References

Hawkey, P. M. (2008). The growing burden of antimicrobial resistance. Journal of Antimicrobial Chemotherapy, 62 (Supplement 1), i1-i9. doi: 10.1093/jac/dkn241.
Talbot, G. H., Bradley, J., Edwards Jr., J. E., Gilbert, D., Scheld, M., Bartlett, J. G., et al. (2006). Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Clin Infect Dis., 42 (5), 657-68.

Email Now

Recipient *

Your first name *

Your last name *

Your telephone number

Your e-mail address *

Your CV (2MB limit)

Where are you currently living? *

Your nationality *

Your message * (please edit as appropriate)

Insert previous message below for editing?

You haven’t included a message. Providing a specific message means universities will take your enquiry more seriously and helps them provide the information you need.
Why not add a message here

The information you submit to University of Leeds will only be used by them or their data partners to deal with your enquiry, according to their privacy notice. For more information on how we use and store your data, please read our privacy statement.

* required field

Send a copy to me for my own records.

Your enquiry has been emailed successfully

Search Suggestions

Based on your current searches we recommend the following search filters.

Check out our other PhDs in Leeds, United Kingdom

Check out our other PhDs in Medical / Clinical Science

Start a new search with our database of over 4,000 PhDs

PhD Suggestions

Based on your current search criteria we thought you might be interested in these.

A ’sweet’ new strategy for tackling superbugs: uniting synthetic and biochemical glycoscience for the inhibition of novel carbohydrate processing enzymes in multi-drug resistant bacteria
University of York

Identification of novel combinations of analgesic drugs for an efficient and safe pain relief.
University of Sheffield

Genome mining of novel antimicrobial and antiviral natural products from new bacterial strains
Aberdeen University

Our Sites

Main Menu

Towards new antibacterial drugs to treat infections caused by multidrug-resistant bacteria: identification and characterization of novel natural product antibiotics

University of Leeds Faculty of Biological Sciences

About the Project

Funding Notes

References